NM

Natesavalavan Monalisa

Active Director Director DIN 10626373
DIN 10626373 First appointment May 2024 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value •••• Premium profile

About Natesavalavan Monalisa

Data last updated:

Natesavalavan Monalisa is a Director at Larivin Pharma Private Limited (since 2024). The company operates in Paper. Larivin Pharma Private Limited reported revenue of ₹12.83 Cr (FY 2024).

DIN 10626373
Primary Designation Director
Industry Paper
First Appointment 14 May 2024
Oldest Company Age 3 yrs
Largest company Larivin Pharma Private Limited · ₹12.83 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Larivin Pharma Private Limited U21001TN2023PTC161631
Director14 May 20242023₹12.83 Cr (FY 2024)Active

Board colleagues of Natesavalavan Monalisa

Directorship timeline

Open interactive timeline →
Larivin Pharma Private Limited
Premium access

Shareholding and investment profile for Natesavalavan Monalisa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Natesavalavan Monalisa

Natesavalavan Monalisa currently holds 1 directorship: Larivin Pharma Private Limited (Director, since 14 May 2024, revenue ₹12.83 Cr (FY 2024)).

Natesavalavan Monalisa was first appointed on 14 May 2024 as Director at Larivin Pharma Private Limited.

The current boards of Natesavalavan Monalisa's companies include Ramaiyan Natesavalavan (Larivin Pharma Private Limited), Saravanan Haritha (Larivin Pharma Private Limited), Saravanan Nambiyappan (Larivin Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available